Fast Facts About Extrapolation for Biosimilars

This video provides a brief explanation of the basic tenets of extrapolation as it pertains to biosimilars. (0:50)

Fast Facts About Biologic Drugs

This video provides a high-level overview of what a biological drug is and how it differs from a small molecule drug. (0:47)

Fast Facts About Biosimilars

This video provides a high-level overview of biosimilars. The main goal of biosimilars is to create a drug that is similar to a reference product. (0:42)

You are about to leave the amgencongresses.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.

Mechanism of Action in Psoriatic Arthritis

See how Otezla may work in psoriatic arthritis. The specific mechanism(s) by which apremilast exerts its therapeutic action is not well defined. (3:30)

Otezla Is an Oral Treatment Option for Use in Psoriatic Arthritis Patients

Learn about the PALACE 4 clinical trial data in DMARD-naïve patients. (11:52)

Otezla Is the First and Only FDA-approved Therapy for Adult Patients with Oral Ulcers Associated with Behçet's Disease

Learn about the RELIEF clinical trial data. (11:14)

You are about to leave the amgencongresses.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.

Welcome to Amgen’s Congress Hub.

The information presented here is intended for healthcare professionals in the United States and has been reviewed in accordance with our US headquarter policies.

Are you a healthcare professional?

PROFICIO Clinical Development Program—Introducing VESALIUS-CV

Learn about PROFICIO, Amgen’s program of clinical studies of evolocumab. Introducing VESALIUS-CV, a global initiative exploring the potential of evolocumab for the prevention of first CV events. This is an investigational study. Evolocumab is not indicated for this intended use.

The Role of PCSK9 in the Regulation of LDL Cholesterol

Overview of the mechanism of LDL-C regulation and the role of PCSK9.

Webinar: Guidelines, Discharge Protocol, and Routine Follow-up in Patients with Recent MI

Speakers: Dominick J. Angiolillo, MD, PhD, FACC | Carl (Chip) Lavie, Jr, MD, FACC

How Have Cholesterol Guidelines Changed?

Watch how LDL-C levels recommended by multiple cholesterol guidelines have decreased over time and understand current recommendations for very high-risk patients.

Podcast: Why It's Time to Reassess LDL‑C Goals in Your Patients with...

Learn how we can better manage cholesterol in high-risk patients and help reduce the risk of subsequent CV events.
Host: Pam R. Taub, MD, FACC, FASPC
Guest: Sripal Bangalore, MD, MHA

EVENITY^® Mechanism of Action Video Featuring Dr. Dempster

Learn about the MOA for EVENITY^® (romosozumab-aqqg) in treatment of post-menopausal women who are at high risk of fracture.

Prolia^® Mechanism of Action Video

Learn more about the Prolia^® MOA for treatment of post-menopausal osteoporosis.

SEAM-RA Study

Watch Dr. Amar Majjhoo discuss the results of the SEAM-RA clinical trial on ENBREL as a monotherapy for maintaining remission in patients with RA. (29:06)

SEAM-PsA Study

Watch Dr. Lawrence Leventhal discuss the results of the SEAM-PsA clinical trial on ENBREL as a monotherapy for treating patients with PsA. (19:36)

Embark^® – an app designed to support the ENBREL patient experience

The Embark App provides patients with financial support information, medication reminders, injection site tracking & more—all in the palm of their hand. (4:05)

ENBREL Nurse Partners™

Watch a video about ENBREL Nurse Partners™ and how they can help your patient prepare for their first injection at home with supplemental support. (2:44)

ENBREL Support^®

Watch a video about ENBREL Support^® services that provides helpful information for your patients on prescribed ENBREL therapy. (2:22)

You are about to leave the amgencongresses.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.